- / Nov 26, 2024 / Business Wire / UnitedHealth Group (NYSE: UNH) will host its annual Investor Conference for analysts and institutional investors in New York City on Wednesday, December 4, 2024, beginning at 8:00 a.m. EST.
UnitedHealth Group leaders will discuss the company’s long-term strategic growth priorities and its efforts to advance high-quality health care, including through a continued focus on improving the consumer experience and expanding value-based care. Management will also provide its outlook for growth and performance in 2025.
The company will stream the presentations and management question and answer sessions and will make conference materials available on its Investor Relations page at www.unitedhealthgroup.com. A replay of the conference will be available on the Company website.
About UnitedHealth Group
UnitedHealth Group (NYSE: UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range of health benefits, enabling affordable coverage, simplifying the health care experience and delivering access to high-quality care. Visit UnitedHealth Group at www.unitedhealthgroup.com and follow UnitedHealth Group on LinkedIn.
Last Trade: | US$525.00 |
Daily Change: | 10.75 2.09 |
Daily Volume: | 3,489,387 |
Market Cap: | US$483.150B |
October 15, 2024 July 16, 2024 May 23, 2024 September 12, 2023 August 17, 2023 |
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREEnd of content
No more pages to load